Alignment Healthcare, Inc. (ALHC) — Financial statements
Income statement, balance sheet, and cash flow for Alignment Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,949↑46.1% | 2,704↑48.3% | 1,824↑27.2% | 1,434↑22.8% | 1,168 | |
| Cost of Revenue | 3,460↑43.8% | 2,407↑48.3% | 1,623↑29.8% | 1,250↑20.3% | 1,039 | |
| Gross Profit | 489↑64.7% | 297↑47.6% | 201↑9.1% | 184↑43.2% | 129 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 371↑20.8% | 307↑4.0% | 296↑1.6% | 291 | |
| Other Expenses | 474↑1663.2% | 27↑25.5% | 21↑24.0% | 17↑9.2% | 16 | |
| Operating Expenses | 474↑19.0% | 398↑21.1% | 329↑5.1% | 313↑2.0% | 307 | |
| Total Costs & Expenses | 3,934↑40.2% | 2,805↑43.7% | 1,951↑24.9% | 1,563↑16.1% | 1,346 | |
| Operating Results | ||||||
| Operating Income | 15↑114.5% | -102↑20.5% | -128↑0.6% | -129↑27.8% | -178 | |
| Depreciation & Amortization | 30↑12.6% | 27↑24.9% | 22↑23.9% | 17↑9.1% | 16 | |
| EBITDA | 45↑158.5% | -77↑26.5% | -105↑7.2% | -114↑29.8% | -162 | |
| EBIT | 15↑114.2% | -105↑17.7% | -127↑3.1% | -131↑26.3% | -178 | |
| Interest & Other Income | ||||||
| Net Interest Income | -16↑32.9% | -24↓10.9% | -21↓16.1% | -18↓4.9% | -17 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 16↓32.9% | 24↑10.9% | 21↑16.1% | 18↑4.9% | 17 | |
| Non-Operating Income | -0.09↓103.0% | 3↑445.6% | -0.85↓136.0% | 2↑1135.8% | -0.23 | |
| Other Income / Expenses | -16↑40.7% | -26↓30.0% | -20↑1.4% | -21↓20.0% | -17 | |
| Income Before Tax | -0.96↑99.3% | -128↑13.6% | -148↑0.7% | -149↑23.5% | -195 | |
| Income Tax Expense | 0.02↓4.8% | 0.02↑195.5% | -0.02↓106.5% | 0.34 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -0.98↑99.2% | -128↑13.6% | -148↑1.0% | -150↑23.4% | -195 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -0.72↑99.4% | -128↑13.5% | -148↑1.0% | -150↑23.4% | -195 | |
| Bottom-Line Net Income | -0.72↑99.4% | -128↑13.5% | -148↑1.0% | -150↑23.4% | -195 | |
| EPS (Basic) | -0.00↑99.4% | -0.67↑15.2% | -0.79↑4.8% | -0.83↑27.2% | -1.14 | |
| EPS (Diluted) | -0.00↑99.4% | -0.67↑15.2% | -0.79↑4.8% | -0.83↑27.2% | -1.14 | |
| Weighted Average Shares | 198↑3.8% | 191↑2.5% | 186↑2.8% | 181↑5.4% | 172 | |
| Weighted Average Diluted Shares | 198↑3.8% | 191↑2.5% | 186↑2.8% | 181↑5.4% | 172 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.